- Home
- ORGO vs SENS Comparison
ORGO vs SENS Comparison
Compare ORGO & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGO
- SENS
- Stock Information
- Founded
- ORGO 1985
- SENS 1996
- Country
- ORGO United States
- SENS United States
- Employees
- ORGO N/A
- SENS N/A
- Industry
- ORGO Biotechnology: Pharmaceutical Preparations
- SENS Industrial Machinery/Components
- Sector
- ORGO Health Care
- SENS Industrials
- Exchange
- ORGO Nasdaq
- SENS Nasdaq
- Market Cap
- ORGO 384.4M
- SENS 396.0M
- IPO Year
- ORGO N/A
- SENS N/A
- Fundamental
- Price
- ORGO $3.46
- SENS $0.50
- Analyst Decision
- ORGO Buy
- SENS Strong Buy
- Analyst Count
- ORGO 2
- SENS 3
- Target Price
- ORGO $5.50
- SENS $1.70
- AVG Volume (30 Days)
- ORGO 911.8K
- SENS 5.7M
- Earning Date
- ORGO 08-07-2025
- SENS 08-07-2025
- Dividend Yield
- ORGO N/A
- SENS N/A
- EPS Growth
- ORGO N/A
- SENS N/A
- EPS
- ORGO N/A
- SENS N/A
- Revenue
- ORGO $458,760,000.00
- SENS $23,682,000.00
- Revenue This Year
- ORGO $2.62
- SENS $60.14
- Revenue Next Year
- ORGO $12.46
- SENS $36.55
- P/E Ratio
- ORGO N/A
- SENS N/A
- Revenue Growth
- ORGO 5.35
- SENS 1.64
- 52 Week Low
- ORGO $2.28
- SENS $0.25
- 52 Week High
- ORGO $6.71
- SENS $1.40
- Technical
- Relative Strength Index (RSI)
- ORGO 54.42
- SENS 39.67
- Support Level
- ORGO $3.13
- SENS $0.50
- Resistance Level
- ORGO $3.36
- SENS $0.52
- Average True Range (ATR)
- ORGO 0.21
- SENS 0.02
- MACD
- ORGO 0.08
- SENS 0.00
- Stochastic Oscillator
- ORGO 74.36
- SENS 17.40
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About SENS Senseonics Holdings Inc.
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.